Submission Details
| 510(k) Number | K131184 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2013 |
| Decision Date | August 30, 2013 |
| Days to Decision | 127 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K131184 is an FDA 510(k) clearance for the INTEGRA LICOX PTO2 MONITOR, a Device, Monitoring, Intracranial Pressure (Class II — Special Controls, product code GWM), submitted by Integra Lifesciences Corp. (Burlington, US). The FDA issued a Cleared decision on August 30, 2013, 127 days after receiving the submission on April 25, 2013. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1620.
| 510(k) Number | K131184 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 25, 2013 |
| Decision Date | August 30, 2013 |
| Days to Decision | 127 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GWM — Device, Monitoring, Intracranial Pressure |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1620 |